Form 8-K - Current report:
SEC Accession No. 0001193125-25-142045
Filing Date
2025-06-17
Accepted
2025-06-17 16:05:34
Documents
12
Period of Report
2025-06-17
Items
Item 5.07: Submission of Matters to a Vote of Security Holders

Document Format Files

Seq Description Document Type Size
1 8-K d939241d8k.htm   iXBRL 8-K 32212
  Complete submission text file 0001193125-25-142045.txt   149015

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA rptx-20250617.xsd EX-101.SCH 2512
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE rptx-20250617_lab.xml EX-101.LAB 18666
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE rptx-20250617_pre.xml EX-101.PRE 11673
14 EXTRACTED XBRL INSTANCE DOCUMENT d939241d8k_htm.xml XML 3906
Mailing Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9
Business Address 7171 FREDERICK BANTING SUITE 270, BUILDING 2 SAINT-LAURENT A8 H4S 1Z9 (857) 412-7018
Repare Therapeutics Inc. (Filer) CIK: 0001808158 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39335 | Film No.: 251053320
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)